Jehanzeb Noor - 20 Feb 2026 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: Senior Vice President, Chief Strategy, Innovation & Business Development Officer
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Jehanzeb Noor (power of attorney previously filed)
Issuer symbol: ZBH
Transactions as of: 20 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 24 Feb 2026, 21:04:11 UTC
Previous filing: 03 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Noor Jehanzeb	Senior Vice President, Chief Strategy, Innovation & Business Development Officer	345 E. MAIN STREET, WARSAW	/s/ Matthew R. St. Louis, Attorney-in-Fact for Jehanzeb Noor (power of attorney previously filed)	24 Feb 2026	0002059755

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Restricted Stock Units	Award	$0	+10,076		$0.000000	10,076	20 Feb 2026	Common Stock	10,076		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each RSU represents a contingent right to receive one share of Company common stock.
F2	Vests annually over three years in increments of one-third each year, commencing February 20, 2027.

Remarks:

Senior Vice President, Chief Strategy, Innovation & Business Development Officer